New York, NY, United States of America

Hans C Reiser

USPTO Granted Patents = 1 



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hans C Reiser

Introduction

Hans C Reiser is a notable inventor based in New York, NY (US). He has made significant contributions to the field of molecular biology and pharmacology. His work focuses on methods and molecules that are essential for understanding receptor interactions.

Latest Patents

Hans C Reiser holds a patent for "Methods and molecules useful for identifying molecules that bind LFA-1 and for determining receptor occupancy." This invention relates to a method for identifying molecules that bind the R7.1 epitope of LFA-1 or bind LFA-1 in a way that modifies the R7.1 epitope. The patent also includes methods for determining the occupancy of the LFA-1 receptor by these molecules after administration to a subject. This innovative work is crucial for advancing therapeutic strategies.

Career Highlights

Reiser is currently associated with Boehringer Ingelheim Pharmaceuticals, Inc., where he continues to contribute to groundbreaking research. His expertise in molecular interactions has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Joseph R Woska, Jr. and Robert Rothlein. Their collaborative efforts have further enhanced the research and development initiatives within their organization.

Conclusion

Hans C Reiser's contributions to the field of molecular biology through his innovative patent and work at Boehringer Ingelheim Pharmaceuticals, Inc. highlight his importance as an inventor. His research continues to pave the way for advancements in understanding receptor interactions and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…